Close Menu

Vaccine Authorization

The UK has given emergency authorization for the SARS-CoV-2 vaccine from Pfizer and BioNTech, the Associated Press reports.

The firms announced last month that data from their late-stage clinical trial indicated their mRNA-based candidate vaccine has a 95 percent efficacy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.